Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
683M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
371M
-
Shares change
-
+10M
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$30.8M
-
Put/Call ratio
-
0.26
-
Number of buys
-
39
-
Number of sells
-
-24
-
Price
-
$3.22
Significant Holders of Roivant Sciences Ltd. - Common shares, par value $0.0000000341740141 per share (ROIV) as of Q3 2022
86 filings reported holding ROIV - Roivant Sciences Ltd. - Common shares, par value $0.0000000341740141 per share as of Q3 2022.
Roivant Sciences Ltd. - Common shares, par value $0.0000000341740141 per share (ROIV) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 371M shares
of 683M outstanding shares and own 54.22% of the company stock.
Largest 10 shareholders include QVT Financial LP (129M shares), SB INVESTMENT ADVISERS (UK) LTD (99.4M shares), VIKING GLOBAL INVESTORS LP (88.2M shares), Two Seas Capital LP (5.87M shares), BlackRock Inc. (5.32M shares), SC CHINA HOLDING Ltd (5.21M shares), Anchorage Capital Group, L.L.C. (4.83M shares), FMR LLC (4.18M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.7M shares), and Woodline Partners LP (2.5M shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.